InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.19
(
-0.34%
)
Bitcoin
60,934.94
(
0.20%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5376
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: re-actor post# 8986

Sunday, 02/12/2012 4:13:43 PM

Sunday, February 12, 2012 4:13:43 PM

Post# of 26138
You are correct but I believe that the product will be marketed to 4 target groups

- Women with HHSD - not all post menopausal women suffer from HHSD
- Post menopausal women with testosterone deficiency
- Post menopausal women at risk to cardiovascular disease
- Improving cognitive function in menopausal and post menopausal women which is being studied in Australia

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up